Agilent Technologies, Inc. $A Holdings Cut by Robeco Schweiz AG

Robeco Schweiz AG decreased its holdings in Agilent Technologies, Inc. (NYSE:A) by 3.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,164,837 shares of the medical research company’s stock after selling 39,950 shares during the quarter. Agilent Technologies comprises approximately 3.4% of Robeco Schweiz AG’s portfolio, making the stock its 2nd biggest position. Robeco Schweiz AG owned 0.41% of Agilent Technologies worth $149,507,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Forum Financial Management LP boosted its stake in shares of Agilent Technologies by 2.5% during the 3rd quarter. Forum Financial Management LP now owns 2,921 shares of the medical research company’s stock valued at $375,000 after purchasing an additional 70 shares in the last quarter. Wedmont Private Capital boosted its holdings in shares of Agilent Technologies by 2.3% during the 3rd quarter. Wedmont Private Capital now owns 3,630 shares of the medical research company’s stock valued at $503,000 after buying an additional 81 shares in the last quarter. waypoint wealth counsel grew its position in shares of Agilent Technologies by 4.3% in the 3rd quarter. waypoint wealth counsel now owns 1,984 shares of the medical research company’s stock worth $255,000 after buying an additional 82 shares during the period. Verdence Capital Advisors LLC increased its stake in shares of Agilent Technologies by 5.0% in the 2nd quarter. Verdence Capital Advisors LLC now owns 1,818 shares of the medical research company’s stock worth $215,000 after acquiring an additional 86 shares in the last quarter. Finally, M&T Bank Corp lifted its position in Agilent Technologies by 0.4% during the 2nd quarter. M&T Bank Corp now owns 23,205 shares of the medical research company’s stock valued at $2,738,000 after acquiring an additional 86 shares during the period.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on A shares. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They set a “buy” rating and a $165.00 target price for the company. JPMorgan Chase & Co. raised their price objective on Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Evercore ISI raised Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their target price for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Morgan Stanley assumed coverage on Agilent Technologies in a research note on Tuesday, December 2nd. They issued an “overweight” rating on the stock. Finally, Citigroup lifted their price target on Agilent Technologies from $165.00 to $185.00 and gave the stock a “buy” rating in a research report on Tuesday, November 25th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $163.31.

Agilent Technologies Price Performance

A opened at $146.47 on Wednesday. The company’s 50-day simple moving average is $144.62 and its two-hundred day simple moving average is $133.04. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.52 and a current ratio of 1.96. The stock has a market capitalization of $41.52 billion, a P/E ratio of 32.05, a P/E/G ratio of 4.30 and a beta of 1.29. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating analysts’ consensus estimates of $1.58 by $0.01. The company had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. As a group, analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th will be given a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 annualized dividend and a yield of 0.7%. Agilent Technologies’s payout ratio is 22.32%.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 911 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $143.24, for a total value of $130,491.64. Following the transaction, the chief executive officer directly owned 32,058 shares in the company, valued at approximately $4,591,987.92. This trade represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at $4,935,811.54. This represents a 8.61% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 16,401 shares of company stock valued at $2,468,962.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.